Page 31 - Human Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced the launch of CRMSynced™, an educational initiative that uses gamification to encourage healthcare professionals (HCPs) to prioritize a holistic approach to care for cardio-renal-metabolic (C-R-M) conditions. Accounting for up to 20 million ...

Boehringer Ingelheim and Eli Lilly and Company today announced the launch of CRMSynced ™ an educational initiative that uses gamification to encourage healthcare professionals to prioritize a holistic approach to care for cardio-renal-metabolic conditions. Accounting for up to 20 million deaths in the U.S. annually, C-R-M conditions, including diabetes, heart disease and chronic kidney disease, are the leading ...

Boehringer Ingelheim is focused on helping keep horses safe and “sound” when it comes to stress with the release of a music track, called Equine Relax Trax, specially designed to help reduce stress in horses.

Columbia Clinic signed a cooperation agreement with Boehringer Ingelheim The German rehabilitation model has taken root in China and has been contributing to the Healthy China 2030 News provided by Share this article SHANGHAI, Aug. 4, 2021 /PRNewswire/ -- On August 3 rd, 2021, Columbia China, signed a cooperation agreement with Consanas Rehabilitation, brand of Boehringer Ingelheim. The agreement will allow both parties to complement each other's medical resources and to carry out in-depth collaboration on talent exchange, which effectively feeds into healthcare delivery and further impro...

Search jobs First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development Breakthrough results in the treatment of a type of heart failure, which is extremely difficult to manage Strong progress in mental health pipeline Good business performance in all areas, despite ongoing impact of COVID-19 Ingelheim, August 3, 2021 – In the first half of 2021, Boehringer Ingelheim has supplied more humans and animals worldwide with innovative medicines than ever before. The company’s success is based on its rich R&D portfolio with a focus on...